Functional cardiomyocytes from human embryonic stem cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 3, 2009
Grant Date -
Jun 3, 2004
app pub date -
Jul 25, 2003
filing date -
Jul 26, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Human embryonic stem cells form embryoid bodies in culture which contain differentiated human cells. Some of the human cells in embryoid bodies differentiate into cardiomyocytes. Here the biological and electrical characteristics of those cardiomyocytes are described with reference to the use of cardiomyocytes derived from human embryonic stem cells in drug screening protocols for mechanisms of cardiac toxicity.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully